These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4720071)

  • 1. Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.
    Nakagawa K; Mashimo K
    J Clin Endocrinol Metab; 1973 Aug; 37(2):238-46. PubMed ID: 4720071
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dexamethasone on plasma growth hormone levels in acromegaly.
    Nakagawa K; Horiuchi Y; Mashimo K
    J Clin Endocrinol Metab; 1970 Nov; 31(5):502-6. PubMed ID: 4919042
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic modulation of growth hormone secretion in acromegaly: suppression during phentolamine and phentolamine-isoproterenol administration.
    Cryer PE; Daughaday WH
    J Clin Endocrinol Metab; 1974 Oct; 39(4):658-63. PubMed ID: 4411883
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered hypothalamic-pituitary-adrenal responsiveness to dexamethasone-insulin tolerance test in active acromegaly.
    Hofeldt FD; Levin SR; Von Werder K; Becker N; Schneider V; Hane S; Seymour R; Adams JE; Forsham PH
    J Clin Endocrinol Metab; 1975 Aug; 41(2):399-401. PubMed ID: 1159053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
    AvRuskin TW; Sau K; Tang S; Juan C
    J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
    Nakagawa K; Akikawa K; Matsubara M; Kubo M
    J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects.
    Mims RB; Stein RB; Bethune JE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):34-9. PubMed ID: 4715294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
    Nakagawa K; Obara T
    J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Permanent and non-suppressable somatotropic hypersecretion in acromegaly].
    Strauch G; Modigliani E; Bricaire H
    Presse Med (1893); 1970 Jan; 78(4):167-70. PubMed ID: 4907364
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different responses of blood amino acids and blood glucose to the administration of insulin to patients with acromegaly.
    Zimmermann-Telschow H; Wiegelmann W; Solbach HG; Zimmermann H
    Horm Metab Res; 1973 Nov; 5(6):474-5. PubMed ID: 4767005
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acromegaly with bromocryptine.
    Summers VK; Hipkin LJ; Diver MH; Davis JC
    J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Cassar J; Mashiter K; Sullivan G; Joplin GF
    Acta Endocrinol (Copenh); 1976 May; 82(1):39-46. PubMed ID: 946714
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma levels of growth hormone and insulin in acromegaly].
    Derot M; Rosselin G; Assan R; Freychet P; Tchobroutsky G
    Ann Endocrinol (Paris); 1966; 27(6):776-83. PubMed ID: 5973131
    [No Abstract]   [Full Text] [Related]  

  • 20. Bronchial carcinoid tumour with acromegaly in two patients.
    Dabek FT
    J Clin Endocrinol Metab; 1974 Feb; 38(2):329-33. PubMed ID: 4812628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.